PB1807: THE SIGNIFICANCE OF MOLECULAR RISK FACTORS IN ACUTE MYELOID LEUKEMIA

PB1807: THE SIGNIFICANCE OF MOLECULAR RISK FACTORS IN ACUTE MYELOID LEUKEMIA

Bibliographic Details
Main Authors:	Alla Gordienko, Nadiya Goryainova, Галина Стародуб, Nataliia Tretiak, Hanna Bortnik
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000974076.55174.45

Similar Items

PB2023: THE LEVEL OF VASCULAR ENDOTHELIAL FACTOR (VEGF) IN THE BLOOD SERUM OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS RAEB I).
by: Галина Стародуб, et al.
Published: (2023-08-01)

CD117 expression on blast cells in acute myeloid leukemia
by: Goryainova N.V., et al.
Published: (2015-09-01)

PB1807: OUTCOME OF CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA IN CHILDREN AND ADOLESCENTS: A SINGLE CENTER EXPERIENCE
by: N. Ben Sayed, et al.
Published: (2022-06-01)

PB1782: INTEGRATIVE MOLECULAR SUBTYPES OF ACUTE MYELOID LEUKEMIA
by: Qianxing Mo, et al.
Published: (2023-08-01)

PB1817: PROGNOSTIC SIGNIFICANCE OF CD200 ON ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA AND ITS MECHANISM
by: X. Quan, et al.
Published: (2022-06-01)

PB1832: INFLAMMATION INDUCED COAGULATION IN ACUTE MYELOID LEUKEMIA
by: Olivera Mitrović Ajtić, et al.
Published: (2023-08-01)

PB1826: CELLULAR AND MOLECULAR CHARACTERIZATION OF THE ANTINEOPLASTIC EFFECTS OF CEPHALOCHROMIN IN MODELS OF ACUTE MYELOID LEUKEMIA
by: Mariane Cristina Do Nascimento, et al.
Published: (2023-08-01)

Molecular targeting in acute myeloid leukemia
by: Seah H. Lim, et al.
Published: (2017-08-01)

Significance of Neuropilin-1 Expression in Acute Myeloid Leukemia
by: Tarif H. Sallam, et al.
Published: (2013-09-01)

Significance of GRP78 expression in acute myeloid leukemias
by: Wróbel Tomasz, et al.
Published: (2014-04-01)

PB1832: ARTERIAL THROMBOSIS AND ACUTE MYELOID LEUKEMIA – IS THERE A CONNECTION?
by: N. Pantic, et al.
Published: (2022-06-01)

PB1847: ACUTE MYELOID LEUKEMIA – IS IT MORE BESIDES GENETIC ABNORMALITIES?
by: M. Urbano, et al.
Published: (2022-06-01)

Significance of molecular-cytogenetic aberrations for the achievement of first remission in de novo acute myeloid leukemia
by: Boriana M. Zaharieva, et al.
Published: (2008-12-01)

Integrative molecular subtypes of acute myeloid leukemia
by: Qianxing Mo, et al.
Published: (2023-05-01)

Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia
by: Barbara Depreter, et al.
Published: (2020-04-01)

Functions and clinical significance of circular RNAs in acute myeloid leukemia
by: Min Zhou, et al.
Published: (2022-11-01)

PB1801: MYCN IS REQUIRED FOR MAINTAINING AN ONCOGENIC CHARACTERISTICS OF LEUKEMIA CELLS IN ACUTE MYELOID LEUKEMIA
by: Nanfang Huang, et al.
Published: (2023-08-01)

PB1823: SECONDARY ACUTE MYELOID LEUKEMIA AND DE NOVO ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES DISTINCT LANDSCAPE, OR THE SAME DISEASE?
by: M. Jagurinoski, et al.
Published: (2022-06-01)

PB1811: BIOLOGIC AND CLINICAL SIGNIFICANCE OF CD7 ABERRANT EXPRESSION IN ACUTE MYELOID LEUKEMIA: A POOR PROGNOSIS MARKER
by: H. Charfi, et al.
Published: (2022-06-01)

PB1834: ACQUIRED FACTOR VII DEFICIENCY ASSOCIATED WITH ACUTE MYELOID LEUKEMIA
by: Haifa Hafsa, et al.
Published: (2023-08-01)

PB1840: MONOCENTRIC EXPERIENCE OF VENETOCLAX-BASED REGIMENS FOR ACUTE MYELOID LEUKEMIA
by: M. Sciumè, et al.
Published: (2022-06-01)

PB1795: BIO-INSPIRED NANOMEDICINE FOR TARGETED ACUTE MYELOID LEUKEMIA IMMUNOTHERAPY
by: X. Wang, et al.
Published: (2022-06-01)

PB1784: CYTOGENETIC LANDSCAPE OF 87 MOROCCAN ACUTE MYELOID LEUKEMIA PATIENTS
by: E. M. Mahtat, et al.
Published: (2022-06-01)

PB1842: EARLY DEATH IN NEWLY DIAGNOSED ADULT ACUTE MYELOID LEUKEMIA
by: N. Siala, et al.
Published: (2022-06-01)

PB1799: KMT2A-REARRANGED PEDIATRIC ACUTE MYELOID LEUKEMIA
by: E. Zerkalenkova, et al.
Published: (2022-06-01)

Prognostic Significance of Flow Cytometric Immunophenotyping in Patients with Acute Myeloid Leukemia
by: Sinan DEMİRCİOĞLU, et al.
Published: (2022-08-01)

Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance
by: Caixia Han, et al.
Published: (2021-04-01)

Cutting Edge Molecular Therapy for Acute Myeloid Leukemia
by: Kenichi Miyamoto, et al.
Published: (2020-07-01)

Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia
by: Piotr Obszański, et al.
Published: (2022-06-01)

Research progress on molecular biomarkers of acute myeloid leukemia
by: Pei-Yuan Yin, et al.
Published: (2023-02-01)

Molecular landscape and targeted therapy of acute myeloid leukemia
by: Runxia Gu, et al.
Published: (2018-11-01)

Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients
by: Mercy Gatua, et al.
Published: (2022-06-01)

Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia
by: Pourrajab F, et al.
Published: (2020-05-01)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
by: Sarah K Tasian, et al.
Published: (2014-03-01)

Acute myeloid leukemia
by: Torsten Haferlach, (Coordinating Author)
Published: (2019-06-01)

Acute myeloid leukemia
by: Gert Ossenkoppele
Published: (2018-06-01)

PB1896: ACUTE MYELOID LEUKEMIA (AML): REAL-WORLD DATA FROM LEBANON
by: Lewis Nasr, et al.
Published: (2023-08-01)

PB1782: ZINC IN THE MODULATION OF THE ANTIPROLIFERATIVE AND CYTOTOXIC EFFECTS OF OLAPARIB IN ACUTE MYELOID LEUKEMIA
by: M. I. Costa, et al.
Published: (2022-06-01)

PB1776: ABC TRANSPORTERS AFFECT THE SENSITIVITY OF ACUTE MYELOID LEUKEMIA BLASTS TO CHEMOTHERAPY
by: E. Cerovska, et al.
Published: (2022-06-01)

PB1801: CHROMOSOMAL ABNORMALITIES DURING THE CLINICAL COURSE OF ADULT ACUTE MYELOID LEUKEMIA
by: O. Zotova, et al.
Published: (2022-06-01)